# Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV

> **NCT05006170** · PHASE2 · UNKNOWN · sponsor: **Chulalongkorn University** · enrollment: 30 (estimated)

## Conditions studied

- Pediatric HIV Infection

## Interventions

- **DRUG:** DTG DT 20 mg
- **DRUG:** DTG DT 25 mg

## Key facts

- **NCT ID:** NCT05006170
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-03
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05006170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05006170, "Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05006170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*